Display options
Share it on

Case Rep Hematol. 2017;2017:2769570. doi: 10.1155/2017/2769570. Epub 2017 Mar 06.

Hereditary Xerocytosis due to Mutations in .

Case reports in hematology

Elisa Fermo, Cristina Vercellati, Anna Paola Marcello, Anna Zaninoni, Richard van Wijk, Nadia Mirra, Cristina Curcio, Agostino Cortelezzi, Alberto Zanella, Wilma Barcellini, Paola Bianchi

Affiliations

  1. U.O.C. Oncoematologia, U.O.S. Fisiopatologia delle Anemie, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
  2. Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, Netherlands.
  3. U.O.C. Pronto Soccorso, Pediatria Ambulatoriale e DH/MAC, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
  4. U.O.S.D. Genetica Medica, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
  5. U.O.C. Oncoematologia, U.O.S. Fisiopatologia delle Anemie, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy; Universita degli Studi di Milano, Milano, Italy.

PMID: 28367341 PMCID: PMC5358460 DOI: 10.1155/2017/2769570

Abstract

Hereditary xerocytosis (HX) is a rare disorder caused by defects of RBC permeability, associated with haemolytic anaemia of variable degree and iron overload. It is sometimes misdiagnosed as hereditary spherocytosis or other congenital haemolytic anaemia. Splenectomy is contraindicated due to increased risk of thromboembolic complications. We report the clinical, haematological, and molecular characteristics of four patients from two unrelated Italian families affected by HX, associated with beta-thalassemia trait and heterozygous pyruvate kinase deficiency, respectively. Two patients had been splenectomised and displayed thrombotic episodes. All patients had iron overload in the absence of transfusion, two of them requiring iron chelation. The diagnosis of HX was confirmed by LoRRca Osmoscan analysis showing a left-shifted curve.

Conflict of interest statement

The authors declare that there is no conflict of interests regarding the publication of this paper.

References

  1. Int J Lab Hematol. 2015 May;37 Suppl 1:85-91 - PubMed
  2. Clin Lab. 2013;59(3-4):421-4 - PubMed
  3. Blood. 2015 Mar 12;125(11):1841 - PubMed
  4. Semin Hematol. 2004 Apr;41(2):165-72 - PubMed
  5. Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):E1162-8 - PubMed
  6. Clin Lab Haematol. 2006 Aug;28(4):270-4 - PubMed
  7. Blood Cells Mol Dis. 2008 Nov-Dec;41(3):261-2 - PubMed
  8. Am J Hematol. 2015 Oct;90(10):921-6 - PubMed
  9. Blood. 2010 Jul 15;116(2):267-9 - PubMed
  10. Br J Haematol. 1998 Nov;103(2):383-6 - PubMed
  11. Blood. 2015 Sep 10;126(11):1273-80 - PubMed
  12. Blood. 2015 Sep 10;126(11):1281-4 - PubMed
  13. Blood. 2012 Aug 30;120(9):1908-15 - PubMed
  14. Acta Haematol. 1968;39(3):183-91 - PubMed
  15. Hemoglobin. 2003 Aug;27(3):139-47 - PubMed
  16. Prenat Diagn. 2001 Dec;21(13):1114-8 - PubMed
  17. Int J Hematol. 2016 Jul;104(1):125-9 - PubMed
  18. Br J Haematol. 1993 Nov;85(3):553-7 - PubMed
  19. Haematologica. 2008 Sep;93(9):1310-7 - PubMed
  20. Clin Genet. 2014 Mar;85(3):293-5 - PubMed
  21. Blood Cells Mol Dis. 2014 Jan;52(1):53-4 - PubMed
  22. Br J Haematol. 1996 May;93(2):303-10 - PubMed
  23. Int J Lab Hematol. 2014 Aug;36(4):e62-5 - PubMed
  24. Acta Paediatr Belg. 1971;25(1):35-43 - PubMed
  25. Blood. 1996 Jun 15;87(12):5392-3 - PubMed
  26. Ann Hematol. 2016 Sep;95(9):1545-6 - PubMed
  27. Nat Commun. 2013;4:1884 - PubMed
  28. Am J Hematol. 2015 Mar;90(3):E35-9 - PubMed
  29. Prenat Diagn. 2003 May;23 (5):380-4 - PubMed
  30. Blood. 1988 May;71(5):1427-31 - PubMed
  31. Am J Hematol. 2014 Dec;89(12 ):1142-6 - PubMed
  32. Blood Cells Mol Dis. 2009 May-Jun;42(3):216-22 - PubMed
  33. Turk J Haematol. 2012 Dec;29(4):425-6 - PubMed
  34. Blood Rev. 2013 Jul;27(4):167-78 - PubMed
  35. Haematologica. 2009 Aug;94(8):1049-59 - PubMed
  36. Blood. 2013 May 9;121(19):3925-35, S1-12 - PubMed

Publication Types